Key Points
- CEO Eric Lefkofsky sold 200,000 Tempus AI shares at an average price of $80.57, generating approximately $16.1 million. The Rule 10b5-1 transaction reduced his position by 19.81%, leaving him with 809,631 shares.
- Tempus AI shares opened at $77.84 after falling 3.1%, despite the stock trading well above its 52-week low. The company remains unprofitable, with a negative net margin and analysts forecasting a full-year loss.
- Recent quarterly results exceeded expectations, with revenue rising 21.6% year over year to $382.5 million and adjusted EPS outperforming estimates. However, analysts maintain an average “Hold” rating and a consensus price target of $69.33, below the reported share price.
Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CEO Ryan Fukushima sold 700 shares of the company's stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $70.00, for a total transaction of $49,000.00. Following the transaction, the chief executive officer owned 15,874 shares in the company, valued at approximately $1,111,180. This trade represents a 4.22% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Ryan Fukushima also recently made the following trade(s):
- On Friday, August 21st, Ryan Fukushima sold 14,286 shares of Tempus AI stock. The stock was sold at an average price of $70.00, for a total transaction of $1,000,020.00.
- On Tuesday, August 18th, Ryan Fukushima sold 41,095 shares of Tempus AI stock. The stock was sold at an average price of $49.61, for a total transaction of $2,038,722.95.
- On Friday, August 7th, Ryan Fukushima sold 20,000 shares of Tempus AI stock. The shares were sold at an average price of $50.04, for a total transaction of $1,000,800.00.
- On Monday, August 3rd, Ryan Fukushima sold 23,818 shares of Tempus AI stock. The stock was sold at an average price of $46.19, for a total transaction of $1,100,153.42.
- On Wednesday, July 8th, Ryan Fukushima sold 33,284 shares of Tempus AI stock. The stock was sold at an average price of $57.39, for a total transaction of $1,910,168.76.
- On Monday, July 6th, Ryan Fukushima sold 10,000 shares of Tempus AI stock. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00.
Tempus AI Price Performance
Shares of TEM opened at $77.84 on Friday. The firm has a market capitalization of $14.04 billion, a PE ratio of -54.06 and a beta of 3.72. The company has a debt-to-equity ratio of 3.06, a current ratio of 3.30 and a quick ratio of 3.16. Tempus AI, Inc. has a 1-year low of $40.77 and a 1-year high of $104.32. The company's fifty day moving average price is $57.19 and its 200-day moving average price is $52.90.
Tempus AI (NASDAQ:TEM - Get Free Report) last issued its earnings results on Thursday, July 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.14) by $0.10. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%.The company had revenue of $382.49 million during the quarter, compared to analyst estimates of $379.69 million. During the same quarter last year, the business posted ($0.22) EPS. The firm's quarterly revenue was up 21.6% on a year-over-year basis. On average, equities research analysts predict that Tempus AI, Inc. will post -1.38 EPS for the current year.
Hedge Funds Weigh In On Tempus AI
A number of large investors have recently bought and sold shares of TEM. WINTON GROUP Ltd purchased a new position in Tempus AI during the second quarter worth approximately $342,000. Engineers Gate Manager LP purchased a new stake in shares of Tempus AI in the second quarter valued at approximately $637,000. Integrated Wealth Concepts LLC purchased a new stake in shares of Tempus AI in the second quarter valued at approximately $145,000. Baird Financial Group Inc. raised its stake in shares of Tempus AI by 3.4% during the 2nd quarter. Baird Financial Group Inc. now owns 30,434 shares of the company's stock worth $1,763,000 after buying an additional 994 shares during the period. Finally, Arizona State Retirement System raised its stake in shares of Tempus AI by 13.3% during the 2nd quarter. Arizona State Retirement System now owns 28,867 shares of the company's stock worth $1,672,000 after buying an additional 3,384 shares during the period. Institutional investors and hedge funds own 24.22% of the company's stock.
Analyst Ratings Changes
TEM has been the subject of a number of research reports. Stifel Nicolaus decreased their target price on Tempus AI from $60.00 to $50.00 and set a "hold" rating for the company in a report on Monday, August 3rd. Cantor Fitzgerald assumed coverage on shares of Tempus AI in a report on Wednesday, September 2nd. They issued an "overweight" rating and a $80.00 price target on the stock. Roth Capital started coverage on shares of Tempus AI in a research report on Tuesday, September 8th. They set a "neutral" rating and a $67.00 price target for the company. Weiss Ratings raised shares of Tempus AI from a "sell (e+)" rating to a "sell (d-)" rating in a report on Friday, September 11th. Finally, Wolfe Research assumed coverage on shares of Tempus AI in a research note on Tuesday, June 2nd. They issued a "peer perform" rating on the stock. Eleven research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $69.33.
Check Out Our Latest Report on TEM
Tempus AI News Summary
Here are the key news stories impacting Tempus AI this week:
- Positive Sentiment: CEO commentary outlining Tempus AI’s growth strategy and projected Medicare revenue has strengthened confidence that reimbursement expansion could provide a significant new revenue stream. Tempus AI Stock Roars Back 92% From July Low After CEO Lays Out Growth Plan
- Positive Sentiment: Morgan Stanley’s updated outlook reportedly incorporated additional reimbursement-driven revenue potential, helping fuel a sharp weekly advance in TEM shares and reinforcing the bullish growth narrative. Tempus AI Is Ripping 30% Higher This Week After Morgan Stanley Boosts Revenue Outlook
- Positive Sentiment: Trading momentum remains strong: shares have rebounded roughly 92% to 95% from the July low, with market capitalization moving above $14 billion. Above-average volume and elevated call-option activity indicate substantial speculative interest. Tempus AI Stock Is Soaring
- Neutral Sentiment: Analysts and market commentators are assessing whether the recent surge can continue. The rally has improved sentiment, but the sharp move also raises the risk of profit-taking and increased volatility. Strength Seen in Tempus
- Negative Sentiment: Zacks cautioned that recent earnings-estimate revision trends may not support another near-term advance, while brokerages maintain an average “Hold” rating. Tempus also remains unprofitable, making the stock particularly sensitive to valuation concerns and changes in growth expectations. Tempus AI Receives Average Hold Rating
About Tempus AI
(
Get Free Report)
Tempus AI, Inc is a healthcare technology company focused on applying artificial intelligence and data analytics to precision medicine. The company combines molecular testing, clinical data and machine learning to help physicians make more informed treatment decisions and support the development of new therapies.
Tempus provides genomic and diagnostic testing services, including testing intended to identify clinically relevant mutations and other biomarkers. Its technology platform also organizes and analyzes clinical and molecular data, while its AI-enabled tools are designed to assist healthcare professionals with patient care, research and workflow management.
The company serves healthcare providers, patients, pharmaceutical companies and biotechnology researchers, primarily in the United States.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
